ALX Oncology loses two directors; board drops below majority independent; cure period triggered

ALX ONCOLOGY HOLDINGS INC

Jack Nielsen resigned April 28 for health; Itziar Canamasas resigned April 30 due to new professional role.
Board reduced to six directors, only three independent, breaching Nasdaq majority requirement.
Company invokes 180-day cure period under Nasdaq Rule 5605(b)(1)(A) to restore independent majority.
Scott Garland reclassified from Class III to Class II director, effective May 1.
Audit, Compensation, and Governance committees reconstituted with Garland, Goodman, Hemrajani.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Itziar Canamasas

member of the Board of Directors

ALXO · ALX ONCOLOGY HOLDINGS INC

Effective: 2024-04-30
Filed: May 2, 2024, 7:59 PM ET

On April 30, 2024, Itziar Canamasas, Ph.D., informed the Company of her resignation as a member of the Board and all committees thereof, effective immediately, due to her taking a new professional position that does not permit her to continue on as a director of the Company.

Departed

Jack Nielsen

member of the Board of Directors

ALXO · ALX ONCOLOGY HOLDINGS INC

Effective: 2024-04-28
Filed: May 2, 2024, 7:59 PM ET

On April 28, 2024, Jack Nielsen informed ALX Oncology Holdings Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and all committees thereof, effective immediately, due to health reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Itziar Canamasas resigned as member of the Board of Directors at ALX ONCOLOGY HOLDINGS INC.

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On April 30, 2024, Itziar Canamasas, Ph.D., informed the Company of her resignation as a member of the Board and all committees thereof, effective immediately, due to her taking a new professional position that does not permit her to continue on as a director of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jack Nielsen resigned as member of the Board of Directors at ALX ONCOLOGY HOLDINGS INC.

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On April 28, 2024, Jack Nielsen informed ALX Oncology Holdings Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and all committees thereof, effective immediately, due to health reasons.

View on SEC.gov

ALX ONCOLOGY HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0000950170-24-052093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.